ADMA Crosses Above Average Analyst Target
June 07, 2024 at 07:21 AM EDT
In recent trading, shares of ADMA Biologics Inc (ADMA) have crossed above the average analyst 12-month target price of $10.50, changing hands for $10.58/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..